Business6 months ago
Novo Nordisk CFO on ‘silver bullet’ to address GLP-1 patents expiring
When Ozempic and Wegovy launched, their bombshell success was only going to be exclusive to their maker—Novo Nordisk—for a matter of time. While the Danish pharma...
